All Stories

  1. Post-Translational Changes in Serum Albumin in Patients with Alcohol-Associated Hepatitis
  2. MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma
  3. MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma
  4. Correction: Bertuzzi et al. Microenvironmental Traits of Classical Hodgkin’s Lymphoma in Adolescents and Their Prognostic Impact. Cancers 2024, 16, 4210
  5. Microenvironmental Traits of Classical Hodgkin’s Lymphoma in Adolescents and Their Prognostic Impact
  6. Female performance in skyrunning: biological and psychosocial aspects
  7. Long‐term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial
  8. Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus
  9. The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis
  10. Safety and efficacy of non-ablative CO2 laser treatment of vulvo-vaginal atrophy in women with history of breast cancer
  11. Association Between Albumin Alterations and Renal Function in Patients With Type 2 Diabetes Mellitus
  12. Development and internal validation of a multivariable model for the prediction of the probability of 1-year readmission to the emergency department for acute alcohol intoxication
  13. Albumin administration in internal medicine: A journey between effectiveness and futility
  14. Predictors of clinical trajectories of patients with acutely decompensated cirrhosis. An external validation of the PREDICT study
  15. Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation
  16. Predictors of clinical trajectories in patients admitted for acutely decompensated cirrhosis: An external validation of the PREDICT study
  17. Effect of ospemifene on vaginal microbiome in postmenopausal women with vulvovaginal atrophy
  18. Mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department for acute alcoholic intoxication: retrospective cohort study
  19. Correction and Prevention of Hyponatremia in Patients With Cirrhosis and Ascites: Post Hoc Analysis of the ANSWER Study Database
  20. A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study
  21. Predictive factors of inhospital mortality for ICU patients with acute-on-chronic liver failure undergoing liver transplantation
  22. Low hemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation
  23. Vaginal metabolites in postmenopausal women with or without vulvo-vaginal atrophy at baseline and after ospemifeme and systemic hormone treatment
  24. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy
  25. Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications
  26. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
  27. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites
  28. Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case–control–control study
  29. Knowledge of genito-urinary syndrome of menopause among Italian gynecologists: the DIADEM survey
  30. Prognostic Role of Bacterial and Fungal Infections in Patients With Liver Cirrhosis With and Without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study
  31. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
  32. Author Correction: Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors: First Italian Clinical Trial
  33. Correction to ‘Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF’ [J Hepatol 2020 (72) 688–701]
  34. Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial
  35. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
  36. Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol for a Single-Center Randomized Controlled Trial
  37. Effective albumin concentration and albumin function improve after long-term albumin therapy in patients with decompensated cirrhosis
  38. Long-term albumin therapy is not futile in patients with cirrhosis and uncomplicated ascites not normalizing on-treatment serum albumin concentration
  39. Subtle changes of c-reactive protein and serum creatinine during the index hospitalization predict early readmission in patients with decompensated cirrhosis
  40. The Analysis of Food Intake in Patients with Cirrhosis Waiting for Liver Transplantation: A Neglected Step in the Nutritional Assessment
  41. Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
  42. Vaginal Health in Menopausal Women
  43. Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol for a Single-Center Randomized Controlled Trial (Preprint)
  44. PS-102-Circulating native albumin in patients with cirrhosis admitted to hospital for acute decompensation and acute-on-chronic liver failure: Relation to serum albumin levels, albumin function, and patient outcomes
  45. SAT-152-Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
  46. A Mediterranean Diet Mix Has Chemopreventive Effects in a Murine Model of Colorectal Cancer Modulating Apoptosis and the Gut Microbiota
  47. MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
  48. Inducing cancer indolence by targeting mitochondrial Complex I is potentiated by blocking macrophage-mediated adaptive responses
  49. Long-term albumin administration in patients with cirrhosis and uncomplicated ascites: the use of serum albumin concentration for personalizing treatment
  50. Predictors of nosocomial acute-on-chronic liver failure for the risk stratification of patients with cirrhosis admitted to hospital with acute decompensation
  51. The residual native albumin predicts albumin dysfunction and outcomes in hospitalized cirrhotic patients with acute decompensation or acute-on-chronic liver failure
  52. Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study
  53. New insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopy
  54. Structure of Epithelial and Stromal Compartments of Vulvar and Vaginal Tissue From Women With Vulvo-Vaginal Atrophy Taking Ospemifene
  55. Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration
  56. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
  57. The use of human albumin in patients with cirrhosis: a European survey
  58. Outcome of bacterial infections complicated or not by acute-on-chronic liver failure in patients with cirrhosis admitted to hospital for acute decompensation
  59. Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study
  60. Bacterial infections with and without acute-on-chronic liver failure in patients with cirrhosis and acute decompensation: Risk factors and outcome
  61. Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts
  62. The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
  63. Molecular and functional characterization of CD133 + stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells
  64. Structural and functional integrity of human serum albumin: Analytical approaches and clinical relevance in patients with liver cirrhosis
  65. Simple and rapid LC–MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress
  66. Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections
  67. In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
  68. Effects of ospemifene on vaginal epithelium of post-menopausal women
  69. Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule
  70. Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis
  71. The TLR10 polymorphism rs4129009 is associated to poor 28-day survival in patients with cirrhosis and acute on chronic liver failure precipitated by bacterial infection
  72. Inadequate Nutrition in Patients with Cirrhosis: The Need of a Personalized Educational Program
  73. Impaired Lipid Profile is a Risk Factor for the Development of Sexual Dysfunction in Women
  74. TLR-10 Single Nucleotide Polymorphism is Associated to Poor Short Term Survival in Cirrhotic Patients with Acute on Chronic Liver Failure Precipitated by Bacterial Infections
  75. Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases
  76. Response to The reduced CO2+ -binding ability of ischaemia-modified albumin is unlikely to be because of oxidative modification of the N-terminus”
  77. Changes in Vaginal Physiology of Menopausal Women with Type 2 Diabetes
  78. Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis
  79. Reply to the Letter to the Editor: How Does Sleep Relate to Metabolic Syndrome in Women with Sexual Dysfunction?
  80. Posttranscriptional changes of serum albumin: Clinical and prognostic significance in hospitalized patients with cirrhosis
  81. Clinical and prognostic relevance of albumin dimers in patients with cirrhosis: A novel identified structural alteration of the molecule
  82. Sexuality and Psychopathological Aspects in Premenopausal Women with Metabolic Syndrome
  83. Endocannabinoids and liver cirrhosis: The endocannabinoid-related molecule oleoyl-ethanolamine (OEA) correlates with clinical complications and 1-year survival
  84. Ischemia modified albumin (IMA) for the diagnosis of bacterial infection in hospitalized patients with cirrhosis
  85. The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives
  86. Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and -β expression of young women
  87. 580 POST-TRANSCRIPTIONAL CHANGES OF SERUM ALBUMIN ARE ASSOCIATED WITH CLINICAL FEATURES AND POOR SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS
  88. OC-35 Post-transcriptional changes of serum albumin and its relationship with clinical features and prognosis in cirrhotic patients
  89. A fast and validated mass spectrometry method for the evaluation of human serum albumin structural modifications in the clinical field
  90. O1 ADMINISTRATION OF THE CANNABINOID CB1-RECEPTOR ANTAGONIST PROTECTS AGAINST SEPSIS IN RAT CIRRHOSIS
  91. Androgen receptor expression in the human vagina under different physiological and treatment conditions
  92. 569 ENDOCANNABINOIDS AND CIRRHOSIS: HAVE WE PICKED THE RIGHT ONE?
  93. F-27 Endocannabinoids in advanced cirrhosis: have we picked the right one?
  94. Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis
  95. Hyperoxia fully protects mitochondria of explanted livers
  96. F.N.10 PHARMACOLOGICAL ANTAGONISM OF ENDOCANNABINOID CB1 RECEPTOR AMELIORATES LIVER FIBROSIS IN A RAT MODEL OF ADVANCED CIRRHOSIS
  97. A novel model of CCl4-induced cirrhosis with ascites in the mouse
  98. 748 EFFECT OF B3-ADRENOCEPTOR MODULATION ON PORTAL PRESSURE IN RATS WITH COMPENSATED CIRRHOSIS
  99. Effect of β3-adrenoceptor agonist SR58611A on portal pressure of rats with compensated cirrhosis
  100. A novel experimental model of decompensated liver cirrhosis induced by CCl4 inhalation in mice
  101. SPASE-I: a multicenter observational study on pharmacological treatment of acute stroke in the elderly
  102. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system